SARS-CoV-2 Envelope Protein Polyclonal antibody

SARS-CoV-2 Envelope Protein Polyclonal Antibody for ELISA

Host / Isotype

Rabbit / IgG

Reactivity

virus

Applications

ELISA

Conjugate

Unconjugated

Cat no : 28904-1-AP

Synonyms

COV19, COV-19, COVID19, COVID-19 E protein, E Protein, envelope protein, SARS-COV-2 E Protein

Validation Data Gallery

  • ELISA experiment of Recombinant protein using 28904-1-AP

    ELISA experiment of Recombinant protein using 28904-1-AP

    SARS-CoV-2 Envelope protein Antibody (28904-1-AP) tested by ELISA. SARS-CoV-2 Envelope protein was coated onto microtiter plates at 0.15 µg/well and then incubated with a dilution series of SARS-CoV-2 Envelope protein Antibody (28904-1-AP). Bound antibodies were detected with HRP conjugated anti-Rabbit IgG followed by incubation with HRP Substrate and then measuring the resulting absorbance at 450 nm.

Tested Applications

Positive ELISA detected inRecombinant protein protein

Recommended dilution

ApplicationDilution
Enzyme-linked Immunosorbent Assay (ELISA)ELISA :
Sample-dependent, check data in validation data gallery

Product Information

28904-1-AP targets SARS-CoV-2 Envelope Protein in ELISA applications and shows reactivity with virus samples.

Tested Reactivity virus
Host / Isotype Rabbit / IgG
Class Polyclonal
Type Antibody
Immunogen SARS-CoV-2 Envelope Protein fusion protein Ag30690
Full Name COVID-19 E Protein
GenBank accession numberNC_045512
Gene symbol COVID-19 E Protein
Gene ID (NCBI) 43740570
Conjugate Unconjugated
Form Liquid
Purification Method Antigen affinity purification
Storage Buffer PBS with 0.1% sodium azide and 50% glycerol pH 7.3.
Storage ConditionsStore at -20°C. Aliquoting is unnecessary for -20oC storage.

Background Information

Envelope protein of coronaviruses is a structural protein existing in both monomeric and homopentameric form. It is a minor component of the virus membrane though it is deemed to be important for many stages including virus infection, replication, dissemination and immune response stimulation. Sequence comparison has shown that this protein is identical to the counterparts of specific Bat and Pangolin coronavirus isolates, even though the Sars-CoV-2 sequence seems to possess specific modifications and characteristics with respect to other Sars CoVs(PMID:32596311). The SARS-CoV-2 envelope protein provide a strategy to assess cross-protection against COVID-19 (PMID: 32446902).